Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.290
+0.010 (0.44%)
Nov 20, 2024, 4:00 PM EST - Market closed
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $135.03 million as of November 21, 2024. Its market cap has increased by 23.00% in one year.
Market Cap
135.03M
Enterprise Value
-86.07M
1-Year Change
23.00%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $135.03M, a decrease of -95.88%. That is a compound annual growth rate of -55.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 135.03M | 9.06% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | 3.33B | 1.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 138.78M |
| Sagimet Biosciences | 137.55M |
| Inhibikase Therapeutics | 135.73M |
| Puma Biotechnology | 132.54M |
| Lineage Cell Therapeutics | 132.21M |
| Cardiol Therapeutics | 130.94M |
| Skye Bioscience | 130.88M |
| Cardiff Oncology | 130.14M |